By identifying the active site and determining the structural requirements for both hepcidin inhibition and stimulation, our structure-function study of ERFE may help inform the design of new therapeutics targeting ERFE or BMPs for the treatment of iron disorders. The gene discussed is ERFE; the disease is iron metabolism disease.